Journal ArticleOPEN ACCESS

Targeted deep sequencing in primary myelofibrosis

  • Tefferi A
  • Lasho T
  • Finke C
  • et al.
Blood Advances (2016) 1(2) 105-111
DOI: 10.1182/bloodadvances.2016000208
N/ACitations
Citations of this article
139Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

More than 80% of patients with PMF harbor DNA variants/mutations other than JAK2/CALR/MPL. Some of these variants/mutations adversely affect overall or leukemia-free survival independent of conventional risk stratification.

Cite

CITATION STYLE

APA

Tefferi, A., Lasho, T. L., Finke, C. M., Elala, Y., Hanson, C. A., Ketterling, R. P., … Pardanani, A. (2016). Targeted deep sequencing in primary myelofibrosis. Blood Advances, 1(2), 105–111. https://doi.org/10.1182/bloodadvances.2016000208

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free